Cancer Grand Challenges latest teams explore T-cell receptor binding prediction and the drivers of pediatric solid tumors.

Researchers have found that the stability of a protein next to its nuclear localization signal sequence impacts the rate of ...

Researchers have developed a vaccine that directs the immune system to produce neutralizing antibodies against HIV.

Researchers have developed a novel biomaterial vaccine capable of priming mouse lymph nodes for enhanced responses to ...

Please enter your username and password below, if you are not yet a member of BioTechniques remember you can register for ...

Organoid models for cancer research can largely be differentiated into two types: tissue-derived organoids and iPSC-derived organoids. In this infographic, part of our InFocus on organoids for cancer ...

In the last decade, organoid technology has transitioned from an exciting prospect in basic research to a paradigm-shifting phenomenon that has shaped policy and changed the face of drug development.

Advanced cell-based approaches, such as 3D cell culture and 2D stem-cell models, are increasingly used to create models of human diseases, such as cancer, allowing researchers to study disease ...

Research has recently been presented highlighting the role that CRISPR-Cas technology can play in tackling antimicrobial ...

The discovery of novel immunotherapies that specifically target and enhance the T cell response against cancer, for example CAR-T cells, bispecific antibodies, and checkpoint inhibitors, is a rapidly ...

Maryna Panamarova (left) is a Cellular Modelling Technical Specialist at the Wellcome Sanger Institute (Cambridge, UK), in the scientific operations department. The scientific operations department ...

In this Application Note, Sartorius describes the use of the Incucyte® Live-Cell Analysis System and Incucyte® 3D Multi-Tumor Spheroid Assays to study the growth of 3D tumor multi-spheroids in ...